Published May 2019 | Version v1
Journal article

Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status

  • 1. Imaging Department, UCLH NHS Trust, London (United Kingdom)
  • 2. Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London (United Kingdom)
  • 3. National Hospital for Neurology and Neurosurgery, Queen Square, London (United Kingdom)
  • 4. Department of Neurodegenerative Diseases, UCL Institute of Neurology, London (United Kingdom)
  • 5. Division of Neuropathology, National Hospital for Neurology and Neurosurgery, Queen Square, London (United Kingdom)

Description

Background and Purpose: There is increasing evidence that many IDH wildtype (IDHwt) astrocytomas have a poor prognosis and although MR features have been identified, there remains diagnostic uncertainty in the clinic. We have therefore conducted a comprehensive analysis of conventional MR features of IDHwt astrocytomas and performed a Bayesian logistic regression model to identify critical radiological and basic clinical features that can predict IDH mutation status.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ejrad.2019.03.003

Additional details

Identifiers

DOI
10.1016/j.ejrad.2019.03.003;
PII
S0720048X19300956;

Publishing Information

Journal Title
European Journal of Radiology
Journal Volume
114
Journal Page Range
p. 120-127
ISSN
0720-048X
CODEN
EJRADR

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51013745
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ASTROCYTOMAS; MUTATIONS; NMR IMAGING; SIMULATION
Descriptors DEC
DIAGNOSTIC TECHNIQUES; DISEASES; GLIOMAS; NEOPLASMS; NERVOUS SYSTEM DISEASES

Optional Information

Notes
© 2019 Elsevier B.V. All rights reserved.